{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_001126112.3:c.30A>T",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "A",
            "alt": "T",
            "position": "30"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "10"
          },
          "Description in input context": "A30P"
        },
        {
          "HGVS": "NM_001126112.3:c.159A>T",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "A",
            "alt": "T",
            "position": "159"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T"
        },
        {
          "HGVS": "NM_001126112.3:c.138G>A",
          "cDNA Change": {
            "transcript": "NM_001126112.3",
            "ref": "G",
            "alt": "A",
            "position": "138"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "E46K"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson disease",
    "MONDO": "MONDO:0005282"
  },
  "Experiment Method": [
    {
      "Assay Method": "Membrane binding assay with cytosolic factors",
      "Material used": {
        "Material Source": "Brain tissue",
        "Material Name": "Brain cytosol",
        "Description": "Co-incubation with brain cytosol to assess alpha-synuclein membrane binding."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.30A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced membrane binding",
          "Result Description": "A30P variant showed impaired membrane binding compared to wild-type."
        },
        {
          "Variant": "NM_001126112.3:c.159A>T",
          "Conclusion": "Normal",
          "Molecular Effect": "Enhanced interaction",
          "Result Description": "A53T variant exhibited increased membrane binding affinity."
        },
        {
          "Variant": "NM_001126112.3:c.138G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Altered conformation",
          "Result Description": "E46K variant displayed disrupted membrane binding dynamics."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type alpha-synuclein used as positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Buffer-only control used to establish baseline."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Membrane binding affinity within physiological range",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Membrane binding affinity deviating by >20% from baseline",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "No",
        "Description": "The method is specific to studying alpha-synuclein interactions rather than a standard PD assay."
      }
    },
    {
      "Assay Method": "Protein-lipid interaction analysis",
      "Material used": {
        "Material Source": "Recombinant proteins",
        "Material Name": "Alpha-synuclein variants",
        "Description": "Assessment of protein-lipid interaction dynamics."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001126112.3:c.30A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced lipid binding",
          "Result Description": "A30P variant showed decreased lipid interaction capacity."
        },
        {
          "Variant": "NM_001126112.3:c.159A>T",
          "Conclusion": "Normal",
          "Molecular Effect": "Enhanced lipid binding",
          "Result Description": "A53T variant demonstrated increased lipid binding affinity."
        },
        {
          "Variant": "NM_001126112.3:c.138G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Altered lipid binding",
          "Result Description": "E46K variant exhibited disrupted lipid interaction patterns."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type alpha-synuclein used as positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Buffer-only control used to establish baseline."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D.",
        "Description": "Not explicitly mentioned in the text."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Lipid binding affinity within physiological range",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Lipid binding affinity deviating by >20% from baseline",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "No",
        "Description": "The method is specific to studying alpha-synuclein interactions rather than a standard PD assay."
      }
    }
  ]
}